Figure 1
From: Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer

Overall survival. N=number of eligible patients. O=total number of events at the final analysis. Subsequent numbers are the number of patients at risk.